Literature DB >> 27326240

Impact of interactions between risk alleles on clinical endpoints in hypertension.

Samantha Kohli1, Rahul Kumar2, Mohit Gupta3, Sanjay Tyagi3, M A Qadar Pasha1.   

Abstract

OBJECTIVE: Impairment of the renin-angiotensinogen-aldosterone system (RAAS), one of the characteristics of essential hypertension (EH), imbalances vascular homeostasis. Despite inconsistent reports on individual single nucleotide polymorphisms (SNPs) as a major predictor of EH, interactions among RAAS genetic variants are rarely investigated.
METHODS: Using SNP markers, we studied potential interactions between angiotensin 1 converting enzyme (ACE), angiotensinogen (AGT), angiotensin II-type 1 receptor (AGTR1), and α adducin (ADD1) variants and their correlation with clinical endpoints in 545 individuals with hypertension and 400 age- and ethnicity-matched unrelated controls. Generalised multifactor dimensionality reduction (GMDR) analysis identified the models for genotype interaction.
RESULTS: Although the results on single genes were significant, gene-gene interactions were more reliable and promising as markers in predisposing hypertension. The best models to represent association of multi-locus interactions with augmented hypertension susceptibility were: (a) within gene 4-locus model comprised of AGT SNPs -217G/A, -20A/C, -6G/A and 235M/T (p=0.022, OR 6.1); and (b) between genes 5-locus model comprised of AGT -217G/A, -20A/C, -6G/A, 235M/T and ACE I/D (p=0.05, OR 4.6). Stratification of 4- and 5-locus GMDR models on the basis of risk alleles from ≤1 to ≥7 increased the ORs from 2.8 to 36.1 and from 0.9 to 16.1, respectively. Moreover, compared to ≤1 risk alleles the ≥7 interacting risk alleles in both 4- and 5-locus models showed an increment of 14.2% and 11.1% in systolic blood pressure, 7.7% and 1.1% in diastolic blood pressure, and 10.5% and 5.1% in mean arterial pressure, respectively, in patients.
CONCLUSIONS: Interactions among the genetic loci of RAAS components may be used as a predictor for susceptibility to hypertension.

Entities:  

Keywords:  GENETICS; HYPERTENSION

Year:  2016        PMID: 27326240      PMCID: PMC4898629          DOI: 10.1136/heartasia-2016-010723

Source DB:  PubMed          Journal:  Heart Asia        ISSN: 1759-1104


  37 in total

Review 1.  New strategies for identifying gene-gene interactions in hypertension.

Authors:  Jason H Moore; Scott M Williams
Journal:  Ann Med       Date:  2002       Impact factor: 4.709

2.  The epistasis between vascular homeostasis genes is apparent in essential hypertension.

Authors:  Rahul Kumar; Azim Nejatizadeh; Mohit Gupta; Amandeep Markan; Sanjay Tyagi; S K Jain; M A Qadar Pasha
Journal:  Atherosclerosis       Date:  2011-11-02       Impact factor: 5.162

3.  Interactions between the genes of vasodilatation pathways influence blood pressure and nitric oxide level in hypertension.

Authors:  Rahul Kumar; Samantha Kohli; Aastha Mishra; Ritu Garg; Perwez Alam; Tsering Stobdan; Azim Nejatizadeh; Mohit Gupta; Sanjay Tyagi; M A Qadar Pasha
Journal:  Am J Hypertens       Date:  2014-08-26       Impact factor: 2.689

4.  Novel variants detected in AGT gene among patients with essential hypertension.

Authors:  G Padma; Bh Charita; N Swapna; M Mamata; T Padma
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2014-01-22       Impact factor: 1.636

5.  Global burden of hypertension: analysis of worldwide data.

Authors:  Patricia M Kearney; Megan Whelton; Kristi Reynolds; Paul Muntner; Paul K Whelton; Jiang He
Journal:  Lancet       Date:  2005 Jan 15-21       Impact factor: 79.321

6.  Association of left ventricular mass with the AGTR1 A1166C polymorphism.

Authors:  Yu Jin; Tatiana Kuznetsova; Lut Thijs; Boris Schmitz; Yanping Liu; Kei Asayama; Stefan-Martin Brand; Stephane Heymans; Eva Brand; Robert Fagard; Jan A Staessen
Journal:  Am J Hypertens       Date:  2012-01-12       Impact factor: 2.689

7.  The G-217A variant of the angiotensinogen gene affects basal transcription and is associated with hypertension in a Taiwanese population.

Authors:  Shyh-Jong Wu; Fu-Tien Chiang; Jun-Ran Jiang; Kwan-Lih Hsu; Tser-Haw Chern; Yung-Zu Tseng
Journal:  J Hypertens       Date:  2003-11       Impact factor: 4.844

8.  Angiotensinogen gene haplotype and hypertension: interaction with ACE gene I allele.

Authors:  Chia-Ti Tsai; Daniele Fallin; Fu-Tien Chiang; Juey-Jen Hwang; Ling-Ping Lai; Kuan-Lih Hsu; Chuen-Den Tseng; Chiau-Suong Liau; Yung-Zu Tseng
Journal:  Hypertension       Date:  2003-01       Impact factor: 10.190

9.  Angiotensin-converting enzyme in the human heart. Effect of the deletion/insertion polymorphism.

Authors:  A H Danser; M A Schalekamp; W A Bax; A M van den Brink; P R Saxena; G A Riegger; H Schunkert
Journal:  Circulation       Date:  1995-09-15       Impact factor: 29.690

10.  Genetic polymorphisms of angiotensinogen and essential hypertension in a Tibetan population.

Authors:  Wenquan Niu; Yue Qi; Weijun Cen; Chaoying Cui; Ciren Zhuoma; Dan Cai; Wenyu Zhou; Changchun Qiu
Journal:  Hypertens Res       Date:  2007-11       Impact factor: 3.872

View more
  3 in total

1.  Effect of ACE, ACE2 and CYP11B2 gene polymorphisms and noise on essential hypertension among steelworkers in China: a case-control study.

Authors:  Xiaohong Zhang; Ying Wang; Yao Zheng; Juxiang Yuan; Junwang Tong; Jingya Xu; Qinglin Li; Peishuai Li; Shoufang Jiang; Zhaoyang Wang; Feng Chai; Xiangwen Li
Journal:  BMC Med Genomics       Date:  2022-02-08       Impact factor: 3.063

2.  ITPKC and SLC11A1 Gene Polymorphisms and Gene-Gene Interactions in Korean Patients with Kawasaki Disease.

Authors:  Kyu Yeun Kim; Yoon Sun Bae; Woohyuk Ji; Dongjik Shin; Ho Seong Kim; Dong Soo Kim
Journal:  Yonsei Med J       Date:  2018-01       Impact factor: 2.759

3.  Epistasis of polymorphisms related to the articular cartilage extracellular matrix in knee osteoarthritis: Analysis-based multifactor dimensionality reduction.

Authors:  Javier Fernández-Torres; Gabriela Angélica Martínez-Nava; Yessica Zamudio-Cuevas; Carlos Lozada; Daniela Garrido-Rodríguez; Karina Martínez-Flores
Journal:  Genet Mol Biol       Date:  2020-03-27       Impact factor: 1.771

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.